BFC Planning, Inc.’s Impact BioMedical IBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100 Hold
17
– – ﹤0.01% 3351
2026
Q1
$131 Hold
17
– – ﹤0.01% 2952
2025
Q4
$110 Hold
17
– – ﹤0.01% 3079
2025
Q3
$145 Buy
+17
New +$135 ﹤0.01% 2836

Other funds holding IBO

BFC Planning, Inc.'s IBO Position: Q2 2026 in Review

BFC Planning, Inc. held its Impact BioMedical (IBO) position steady in Q2 2026 at 17 shares worth $100. The position accounts for ﹤0.01% of the portfolio, ranked #3351.

BFC Planning, Inc. first reported a position in IBO in Q3 2025 and has held it in 4 quarters since. The position peaked at $145 in Q3 2025. 20 funds tracked by Wall St. Rank hold IBO as of Q2 2026.

  • BFC Planning, Inc. held 17 shares of Impact BioMedical worth $100 as of Q2 2026.
  • BFC Planning, Inc. left its Impact BioMedical share count unchanged in Q2 2026.
  • Impact BioMedical made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #3351 holding.
  • BFC Planning, Inc. first reported a position in Impact BioMedical in Q3 2025 and has held it in 4 quarters since.
  • BFC Planning, Inc.'s Impact BioMedical position peaked at $145 in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Impact BioMedical as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.